Citius Oncology (CTOR)

• Market cap: $115M
• 1 day: -3.5%
• 5 days: -16.36%
• 1 month: -20.23%
• 3 months: -19.77%
• 6 months: 54.52%
• Year to date: 15.97%
• 1 year: 2.22%
• 5 years: -86.32%
• 10 years: -86.32%
• Sector: Healthcare
• Industry: Drug Manufacturers - Specialty & Generic

About: Citius Oncology Inc is a specialty pharmaceutical company dedicated to the development and commercialization of critical care products targeting unmet needs with a focus on oncology products. In addition, Citius completed enrollment in its Phase 2b trial of CITI-002 (Halo-Lido), a topical formulation for the relief of hemorrhoids.